Business Description
UnitedHealth Group Inc
NAICS : 524114
SIC : 6324
ISIN : ARBCOM460390
Share Class Description:
BUE:UNH: CedearTotal Employee Number:
390,000Compare
Compare
Traded in other countries / regions
UNH.USAUNH.CanadaUNHH34.Brazil0R0O.UKUNH.MexicoUNH.Germany1UNH.ItalyUNH.ChileUNH.PeruUNH.AustriaUNH.Switzerland IPO Date
2021-02-18Description
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.4 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 3.41 | |||||
Interest Coverage | 4.76 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.11 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.9 | |||||
3-Year EBITDA Growth Rate | -8.9 | |||||
3-Year EPS without NRI Growth Rate | -9.7 | |||||
3-Year FCF Growth Rate | -10.5 | |||||
3-Year Book Growth Rate | 7.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.86 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.8 | |||||
Cash Ratio | 0.27 | |||||
Days Sales Outstanding | 20.02 | |||||
Days Payable | 75.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 10.9 | |||||
3-Year Average Share Buyback Ratio | 1 | |||||
Shareholder Yield % | 2.31 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.8 | |||||
Operating Margin % | 4.19 | |||||
Net Margin % | 2.68 | |||||
EBITDA Margin % | 5.08 | |||||
ROE % | 12.61 | |||||
ROA % | 3.87 | |||||
ROIC % | 6.46 | |||||
3-Year ROIIC % | -12.13 | |||||
ROC (Joel Greenblatt) % | 170.82 | |||||
ROCE % | 9.38 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.07 | |||||
Forward PE Ratio | 31.88 | |||||
PE Ratio without NRI | 25.99 | |||||
Shiller PE Ratio | 22.89 | |||||
Price-to-Owner-Earnings | 21.68 | |||||
PEG Ratio | 64.98 | |||||
PS Ratio | 0.86 | |||||
PB Ratio | 3.94 | |||||
Price-to-Free-Cash-Flow | 19.64 | |||||
Price-to-Operating-Cash-Flow | 16.68 | |||||
EV-to-EBIT | 23.75 | |||||
EV-to-EBITDA | 19.25 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-FCF | 22.36 | |||||
Price-to-Projected-FCF | 1.16 | |||||
Price-to-DCF (Earnings Based) | 1.31 | |||||
Price-to-DCF (FCF Based) | 1.15 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Earnings Yield (Greenblatt) % | 4.21 | |||||
FCF Yield % | 5.1 | |||||
Forward Rate of Return (Yacktman) % | 7.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
UnitedHealth Group Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ARS) | |||
| EPS (TTM) (ARS) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (ARS) | - | ||
| 20-Day SMA (ARS) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (ARS) | 0 - 0 | ||
| Shares Outstanding (Mil) | 908.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
UnitedHealth Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
UnitedHealth Group Inc Stock Events
| Event | Date | Price (ARS) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-28 08:00 | In 108 days | ||
| Third quarter earnings results for 2026 | 2026-10-28 | In 107 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-16 08:00 | In 4 days | ||
| Second quarter earnings results for 2026 | 2026-07-16 | In 3 days | ||
| USD 0.070303 Cash Dividend | 2026-06-12 | -- | ||
| General meeting for 2026 | 2026-06-01 11:00 | -- | ||
| First quarter earnings conference call for 2026 | 2026-04-21 08:00 | -- | ||
| First quarter earnings results for 2026 | 2026-04-21 | -- | ||
| USD 0.066970 Cash Dividend | 2026-03-09 | -- | ||
| Annual report for 2025 | 2026-03-02 | -- |
Show
Entries
UnitedHealth Group Inc Frequently Asked Questions
What is UnitedHealth Group Inc(BUE:UNH)'s stock price today?
The current price of BUE:UNH is ARS0.00. The 52 week high of BUE:UNH is ARS0.00 and 52 week low is ARS0.00.
When is next earnings date of UnitedHealth Group Inc(BUE:UNH)?
The next earnings date of UnitedHealth Group Inc(BUE:UNH) is 2026-07-16.
Does UnitedHealth Group Inc(BUE:UNH) pay dividends? If so, how much?
UnitedHealth Group Inc(BUE:UNH) does not pay dividend.
Press Release
Articles on UnitedHealth Group Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers